Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in active ankylosing spondylitis
2005-005358-27Phase 2Completed
- Sponsor
- Royal Stoke University Hospital
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in ankylosing spondylitis (AS), sponsored by Royal Stoke University Hospital. Primary endpoint: MRI change in spinal and sacroiliac enthesitis/osteitis. Started Apr 2006; status: completed.
02
Drugs
rituximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2005-005358-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005358-27.